vs

Side-by-side financial comparison of American Express (AXP) and Gossamer Bio, Inc. (GOSS). Click either name above to swap in a different company.

American Express is the larger business by last-quarter revenue ($18.9M vs $13.8M, roughly 1.4× Gossamer Bio, Inc.). American Express runs the higher net margin — 15.7% vs -342.3%, a 358.0% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 11.4%).

American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products an...

Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.

AXP vs GOSS — Head-to-Head

Bigger by revenue
AXP
AXP
1.4× larger
AXP
$18.9M
$13.8M
GOSS
Growing faster (revenue YoY)
GOSS
GOSS
+35.7% gap
GOSS
47.1%
11.4%
AXP
Higher net margin
AXP
AXP
358.0% more per $
AXP
15.7%
-342.3%
GOSS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AXP
AXP
GOSS
GOSS
Revenue
$18.9M
$13.8M
Net Profit
$3.0M
$-47.2M
Gross Margin
Operating Margin
-333.6%
Net Margin
15.7%
-342.3%
Revenue YoY
11.4%
47.1%
Net Profit YoY
15.0%
-43.0%
EPS (diluted)
$-0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXP
AXP
GOSS
GOSS
Q1 26
$18.9M
Q4 25
$10.9B
$13.8M
Q3 25
$10.4B
$13.3M
Q2 25
$10.3B
Q1 25
$9.6B
Q4 24
$10.0B
Q3 24
$9.7B
Q2 24
$9.8B
$95.8M
Net Profit
AXP
AXP
GOSS
GOSS
Q1 26
$3.0M
Q4 25
$2.5B
$-47.2M
Q3 25
$2.9B
$-48.2M
Q2 25
$2.9B
Q1 25
$2.6B
Q4 24
$2.2B
Q3 24
$2.5B
Q2 24
$3.0B
$49.2M
Operating Margin
AXP
AXP
GOSS
GOSS
Q1 26
Q4 25
28.2%
-333.6%
Q3 25
36.7%
-369.4%
Q2 25
34.4%
Q1 25
34.6%
Q4 24
27.7%
Q3 24
33.0%
Q2 24
38.6%
54.3%
Net Margin
AXP
AXP
GOSS
GOSS
Q1 26
15.7%
Q4 25
22.5%
-342.3%
Q3 25
27.9%
-362.7%
Q2 25
28.0%
Q1 25
26.8%
Q4 24
21.8%
Q3 24
25.8%
Q2 24
30.7%
51.4%
EPS (diluted)
AXP
AXP
GOSS
GOSS
Q1 26
Q4 25
$3.52
$-0.21
Q3 25
$4.14
$-0.21
Q2 25
$4.08
Q1 25
$3.64
Q4 24
$3.04
Q3 24
$3.49
Q2 24
$4.15
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXP
AXP
GOSS
GOSS
Cash + ST InvestmentsLiquidity on hand
$136.9M
Total DebtLower is stronger
$60.4M
Stockholders' EquityBook value
$34.0M
$-122.8M
Total Assets
$308.9M
$172.2M
Debt / EquityLower = less leverage
1.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXP
AXP
GOSS
GOSS
Q1 26
Q4 25
$742.0M
$136.9M
Q3 25
$1.3B
$180.2M
Q2 25
$197.0M
Q1 25
$261.0M
Q4 24
$221.0M
Q3 24
$120.0M
Q2 24
$188.0M
$354.5M
Total Debt
AXP
AXP
GOSS
GOSS
Q1 26
$60.4M
Q4 25
$56.4B
Q3 25
$57.8B
Q2 25
$58.2B
Q1 25
$51.2B
Q4 24
$49.7B
Q3 24
$53.5B
Q2 24
$51.5B
Stockholders' Equity
AXP
AXP
GOSS
GOSS
Q1 26
$34.0M
Q4 25
$33.5B
$-122.8M
Q3 25
$32.4B
$-82.3M
Q2 25
$32.3B
Q1 25
$31.2B
Q4 24
$30.3B
Q3 24
$29.7B
Q2 24
$29.5B
$81.5M
Total Assets
AXP
AXP
GOSS
GOSS
Q1 26
$308.9M
Q4 25
$300.1B
$172.2M
Q3 25
$297.6B
$208.8M
Q2 25
$295.6B
Q1 25
$282.2B
Q4 24
$271.5B
Q3 24
$271.0B
Q2 24
$272.2B
$373.4M
Debt / Equity
AXP
AXP
GOSS
GOSS
Q1 26
1.78×
Q4 25
1.68×
Q3 25
1.78×
Q2 25
1.80×
Q1 25
1.64×
Q4 24
1.64×
Q3 24
1.80×
Q2 24
1.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXP
AXP
GOSS
GOSS
Operating Cash FlowLast quarter
$-48.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXP
AXP
GOSS
GOSS
Q1 26
Q4 25
$3.1B
$-48.3M
Q3 25
$6.2B
$-36.2M
Q2 25
$4.4B
Q1 25
$4.8B
Q4 24
$5.8B
Q3 24
$-1.8B
Q2 24
$4.5B
$116.3M
Free Cash Flow
AXP
AXP
GOSS
GOSS
Q1 26
Q4 25
$2.3B
Q3 25
$5.6B
Q2 25
$3.7B
Q1 25
$4.3B
Q4 24
$5.3B
Q3 24
$-2.3B
Q2 24
$4.0B
FCF Margin
AXP
AXP
GOSS
GOSS
Q1 26
Q4 25
21.4%
Q3 25
53.6%
Q2 25
36.3%
Q1 25
45.0%
Q4 24
53.1%
Q3 24
-23.3%
Q2 24
40.4%
Capex Intensity
AXP
AXP
GOSS
GOSS
Q1 26
Q4 25
6.6%
0.0%
Q3 25
6.3%
0.0%
Q2 25
6.0%
Q1 25
4.5%
Q4 24
5.0%
Q3 24
4.7%
Q2 24
5.8%
0.0%
Cash Conversion
AXP
AXP
GOSS
GOSS
Q1 26
Q4 25
1.25×
Q3 25
2.15×
Q2 25
1.51×
Q1 25
1.84×
Q4 24
2.66×
Q3 24
-0.72×
Q2 24
1.50×
2.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXP
AXP

Discount revenue$9.5M50%
Other$8.9M47%
Deposits with banks and other$512.0K3%

GOSS
GOSS

Segment breakdown not available.

Related Comparisons